Success Metrics

Clinical Success Rate
100.0%

Based on 18 completed trials

Completion Rate
100%(18/18)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
12%
Ph not_applicable
7
28%
Ph phase_3
1
4%
Ph phase_4
7
28%
Ph phase_2
4
16%

Phase Distribution

3

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
3(13.6%)
Phase 2Efficacy & side effects
4(18.2%)
Phase 3Large-scale testing
1(4.5%)
Phase 4Post-market surveillance
7(31.8%)
N/ANon-phased studies
7(31.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

18 of 20 finished

Non-Completion Rate

10.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

25

all time

Status Distribution
Active(1)
Completed(18)
Terminated(2)
Other(4)

Detailed Status

Completed18
unknown3
Withdrawn2
Suspended1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (13.6%)
Phase 24 (18.2%)
Phase 31 (4.5%)
Phase 47 (31.8%)
N/A7 (31.8%)

Trials by Status

suspended14%
not_yet_recruiting14%
unknown312%
completed1872%
withdrawn28%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT05528718

SMILE Trial - Imaging Sub-Study

Completed
NCT05085873Phase 4

Sodium Oxybate Versus Midazolam for Comfort Sedation

Completed
NCT04640636Phase 4

IM Ketamine vs Midazolam for Suicidal ER Patients

Suspended
NCT05046184Phase 2

Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets

Completed
NCT04248335Phase 4

Effect of Obesity on Proton Pump Inhibitors

Completed
NCT05558449Phase 4

Impact of Virtual Reality Hypno-sedation on Functional Recovery and Anxiety in Foot Surgery With Regional Anesthesia

Completed
NCT03223220Phase 2

Quelling of Excitotoxicity in Acute Stroke With Ketamine

Not Yet Recruiting
NCT06033729Not Applicable

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA

Completed
NCT04220125Phase 4

Preoperative Ketamine and Perioperative Depression

Withdrawn
NCT05057767Not Applicable

Impact of Timing of Midazolam Administration on Incidence of Postoperative Nausea and Vomiting

Completed
NCT04527770Not Applicable

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients

Completed
NCT03490903Not Applicable

Coronary Angiography THerapeutic Virtual Reality

Withdrawn
NCT04643249Phase 1

Drug-drug Interaction Study of KL1333 in Healthy Subjects

Completed
NCT03499730

Does Midazolam Affect Postoperative Pain?

Completed
NCT04485702Phase 1

Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine

Completed
NCT04686058Phase 3

Sedation Techniques for Outpatient Colonoscopy

Completed
NCT03375671Phase 2

Rapid Agitation Control With Ketamine in the Emergency Department

Completed
NCT03461718Phase 2

Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.

Completed
NCT04410211Not Applicable

Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures

Completed
NCT03918889Not Applicable

Effect of Dexmedetomidine in Preventing Cough and Postoperative Pain After Laryngeal Surgery for Cancer

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
25